Literature DB >> 17287396

Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.

Koichi Mishima1, Tetsuro Watabe, Akira Saito, Yasuhiro Yoshimatsu, Natsuko Imaizumi, Shinji Masui, Masanori Hirashima, Tohru Morisada, Yuichi Oike, Makoto Araie, Hitoshi Niwa, Hajime Kubo, Toshio Suda, Kohei Miyazono.   

Abstract

During embryonic lymphatic development, a homeobox transcription factor Prox1 plays important roles in sprouting and migration of a subpopulation of blood vessel endothelial cells (BECs) toward VEGF-C-expressing cells. However, effects of Prox1 on endothelial cellular behavior remain to be elucidated. Here, we show that Prox1, via induction of integrin alpha9 expression, inhibits sheet formation and stimulates motility of endothelial cells. Prox1-expressing BECs preferentially migrated toward VEGF-C via up-regulation of the expression of integrin alpha9 and VEGF receptor 3 (VEGFR3). In mouse embryos, expression of VEGFR3 and integrin alpha9 is increased in Prox1-expressing lymphatic endothelial cells (LECs) compared with BECs. Knockdown of Prox1 expression in human LECs led to decrease in the expression of integrin alpha9 and VEGFR3, resulting in the decreased chemotaxes toward VEGF-C. These findings suggest that Prox1 plays important roles in conferring and maintaining the characteristics of LECs by modulating multiple signaling cascades and that integrin alpha9 may function as a key regulator of lymphangiogenesis acting downstream of Prox1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287396      PMCID: PMC1838981          DOI: 10.1091/mbc.e06-09-0780

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  27 in total

1.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors.

Authors:  J Yamashita; H Itoh; M Hirashima; M Ogawa; S Nishikawa; T Yurugi; M Naito; K Nakao; S Nishikawa
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

2.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.

Authors:  Jeffrey T Wigle; Natasha Harvey; Michael Detmar; Irina Lagutina; Gerard Grosveld; Michael D Gunn; David G Jackson; Guillermo Oliver
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

3.  Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor.

Authors:  Tatiana V Petrova; Taija Mäkinen; Tomi P Mäkelä; Janna Saarela; Ismo Virtanen; Robert E Ferrell; David N Finegold; Dontscho Kerjaschki; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

4.  Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.

Authors:  Jay W Shin; Michael Min; Fréderic Larrieu-Lahargue; Xavier Canron; Rainer Kunstfeld; Lynh Nguyen; Janet E Henderson; Andreas Bikfalvi; Michael Detmar; Young-Kwon Hong
Journal:  Mol Biol Cell       Date:  2005-11-16       Impact factor: 4.138

Review 5.  Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology.

Authors:  M H Witte; M J Bernas; C P Martin; C L Witte
Journal:  Microsc Res Tech       Date:  2001-10-15       Impact factor: 2.769

6.  Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation.

Authors:  M Fujii; K Takeda; T Imamura; H Aoki; T K Sampath; S Enomoto; M Kawabata; M Kato; H Ichijo; K Miyazono
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

7.  Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.

Authors:  T Mäkinen; T Veikkola; S Mustjoki; T Karpanen; B Catimel; E C Nice; L Wise; A Mercer; H Kowalski; D Kerjaschki; S A Stacker; M G Achen; K Alitalo
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

8.  Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1.

Authors:  X Z Huang; J F Wu; R Ferrando; J H Lee; Y L Wang; R V Farese; D Sheppard
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 9.  Lymphatic vessels as targets of tumor therapy?

Authors:  T Karpanen; K Alitalo
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

10.  Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.

Authors:  E Kriehuber; S Breiteneder-Geleff; M Groeger; A Soleiman; S F Schoppmann; G Stingl; D Kerjaschki; D Maurer
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  57 in total

Review 1.  Head and neck lymphatic tumors and bony abnormalities: a clinical and molecular review.

Authors:  Karthik Balakrishnan; Mark Majesky; Jonathan A Perkins
Journal:  Lymphat Res Biol       Date:  2011       Impact factor: 2.589

2.  miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo.

Authors:  Deena M Leslie Pedrioli; Terhi Karpanen; Vasilios Dabouras; Giorgia Jurisic; Glenn van de Hoek; Jay W Shin; Daniela Marino; Roland E Kälin; Sebastian Leidel; Paolo Cinelli; Stefan Schulte-Merker; André W Brändli; Michael Detmar
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

Review 3.  Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function.

Authors:  Helge Wiig; Doruk Keskin; Raghu Kalluri
Journal:  Matrix Biol       Date:  2010-08-18       Impact factor: 11.583

4.  Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles.

Authors:  Shiv K Gupta; Nicholas E Vlahakis
Journal:  Cell Adh Migr       Date:  2010-04-08       Impact factor: 3.405

5.  Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.

Authors:  Markku Miettinen; Zeng-Feng Wang
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

Review 6.  The lymphatic system in health and disease.

Authors:  Leah N Cueni; Michael Detmar
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

Review 7.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

8.  Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate.

Authors:  Sunju Lee; Jinjoo Kang; Jaehyuk Yoo; Sathish K Ganesan; Sarah C Cook; Berenice Aguilar; Swapnika Ramu; Juneyong Lee; Young-Kwon Hong
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

9.  Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Authors:  Michael J Flister; Andrew Wilber; Kelly L Hall; Caname Iwata; Kohei Miyazono; Riccardo E Nisato; Michael S Pepper; David C Zawieja; Sophia Ran
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

10.  alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation.

Authors:  Tatsuma Okazaki; Amy Ni; Oluwasheyi A Ayeni; Peter Baluk; Li-Chin Yao; Doerte Vossmeyer; Gunther Zischinsky; Grit Zahn; Jochen Knolle; Claudia Christner; Donald M McDonald
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.